These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
527 related articles for article (PubMed ID: 6307248)
21. Influence of vaccination with avirulent herpesvirus on subsequent infection of chickens with virulent Marek's disease herpesvirus. Spencer JL; Robertson A Am J Vet Res; 1975 Aug; 36(08):1235-9. PubMed ID: 168799 [TBL] [Abstract][Full Text] [Related]
22. Turkey herpesvirus infection in chickens: induction of lymphoproliferative lesions and characterization of vaccinal immunity against Marek's disease. Witter RL; Sharma JM; Offenbecker L Avian Dis; 1976; 20(4):676-92. PubMed ID: 186008 [TBL] [Abstract][Full Text] [Related]
23. Immunosuppressive effects of Marek's disease virus (MDV) and herpesvirus of turkeys (HVT) in broiler chickens and the protective effect of HVT vaccination against MDV challenge. Islam AF; Wong CW; Walkden-Brown SW; Colditz IG; Arzey KE; Groves PJ Avian Pathol; 2002 Oct; 31(5):449-61. PubMed ID: 12427339 [TBL] [Abstract][Full Text] [Related]
24. In situ production of interferon in tissues of chickens exposed as embryos to turkey herpesvirus and Marek's disease virus. Sharma JM Am J Vet Res; 1989 Jun; 50(6):882-6. PubMed ID: 2475045 [TBL] [Abstract][Full Text] [Related]
25. Kinetics of Marek's disease virus (MDV) infection in broiler chickens 1: effect of varying vaccination to challenge interval on vaccinal protection and load of MDV and herpesvirus of turkey in the spleen and feather dander over time. Fakhrul Islam AF; Walkden-Brown SW; Groves PJ; Underwood GJ Avian Pathol; 2008 Jun; 37(3):225-35. PubMed ID: 18568648 [TBL] [Abstract][Full Text] [Related]
26. In Ovo Vaccination with Turkey Herpesvirus Hastens Maturation of Chicken Embryo Immune Responses in Specific-Pathogen-Free Chickens. Gimeno IM; Faiz NM; Cortes AL; Barbosa T; Villalobos T; Pandiri AR Avian Dis; 2015 Sep; 59(3):375-83. PubMed ID: 26478155 [TBL] [Abstract][Full Text] [Related]
28. Marek's disease tumors in chickens vaccinated with turkey herpesvirus vaccine. Eidson CS Dev Biol Stand; 1982; 52():437-46. PubMed ID: 7166202 [TBL] [Abstract][Full Text] [Related]
29. Characterization of four very virulent Argentinian strains of Marek's disease virus and the influence of one of those isolates on synergism between Marek's disease vaccine viruses. Buscaglia C; Nervi P; Risso M Avian Pathol; 2004 Apr; 33(2):190-5. PubMed ID: 15276986 [TBL] [Abstract][Full Text] [Related]
30. Partial inhibition by turkey herpesvirus of serotype 2 Marek's disease virus plaque formation and in vivo infectivity. Witter RL; Bacon LD; Calvert JG Avian Dis; 1994; 38(4):800-9. PubMed ID: 7702514 [TBL] [Abstract][Full Text] [Related]
31. Duration of vaccinal immunity against Marek's disease. Witter RL; Offenbecker L Avian Dis; 1978; 22(3):396-408. PubMed ID: 211999 [TBL] [Abstract][Full Text] [Related]
32. Marek's disease--the disease and its prevention by vaccination. Biggs PM Br J Cancer Suppl; 1975 Mar; 2():152-5. PubMed ID: 170953 [TBL] [Abstract][Full Text] [Related]
33. The efficacy of recombinant fowlpox vaccine protection against Marek's disease: its dependence on chicken line and B haplotype. Lee LF; Bacon LD; Yoshida S; Yanagida N; Zhang HM; Witter RL Avian Dis; 2004; 48(1):129-37. PubMed ID: 15077806 [TBL] [Abstract][Full Text] [Related]
34. Efficacy in chickens of a herpesvirus of turkeys recombinant vaccine containing the fusion gene of Newcastle disease virus: onset of protection and effect of maternal antibodies. Morgan RW; Gelb J; Pope CR; Sondermeijer PJ Avian Dis; 1993; 37(4):1032-40. PubMed ID: 8141730 [TBL] [Abstract][Full Text] [Related]
35. Protection of chickens against very virulent infectious bursal disease virus (IBDV) and Marek's disease virus (MDV) with a recombinant MDV expressing IBDV VP2. Tsukamoto K; Kojima C; Komori Y; Tanimura N; Mase M; Yamaguchi S Virology; 1999 May; 257(2):352-62. PubMed ID: 10329546 [TBL] [Abstract][Full Text] [Related]
36. Effects of T-2 Toxin on Turkey Herpesvirus-Induced Vaccinal Immunity Against Marek's Disease. Kufuor-Mensah E; Reed WM; Sleight S; Pestka J; Fadly AM; Dunn JR Avian Dis; 2016 Mar; 60(1):56-62. PubMed ID: 26953944 [TBL] [Abstract][Full Text] [Related]
37. Vaccinal control of Marek's disease: current challenges, and future strategies to maximize protection. Baigent SJ; Smith LP; Nair VK; Currie RJ Vet Immunol Immunopathol; 2006 Jul; 112(1-2):78-86. PubMed ID: 16682084 [TBL] [Abstract][Full Text] [Related]
38. Derivation, safety and efficacy of a Marek's disease vaccine developed from an Australian isolate of very virulent Marek's disease virus. Karpathy RC; Firth GA; Tannock GA Aust Vet J; 2002; 80(1-2):61-6. PubMed ID: 12180882 [TBL] [Abstract][Full Text] [Related]
39. Early infection with Marek's disease virus can jeopardize protection conferred by laryngotracheitis vaccines: a method to study MDV-induced immunosuppression. Faiz NM; Cortes AL; Guy JS; Fletcher OJ; West M; Montiel E; Gimeno IM Avian Pathol; 2016 Dec; 45(6):606-615. PubMed ID: 27207594 [TBL] [Abstract][Full Text] [Related]
40. Towards a mechanistic understanding of the synergistic response induced by bivalent Marek's disease vaccines to prevent lymphomas. Umthong S; Dunn JR; Cheng HH Vaccine; 2019 Oct; 37(43):6397-6404. PubMed ID: 31515142 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]